NCT05863052Active, not recruiting
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population Treated With Immune Checkpoint Inhibitors for Various Cancers
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to future interventional studies.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 72 (estimated)
- First submitted
- 13 Mar 2023
- Start date
- 31 Jan 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Oklahoma
- Diseases
- Kidney cancer, Melanoma, Lung cancer
- NCT number
- NCT05863052
What you commit to
- Study type: Observational
- Planned participants: 72
- From 31 Jan 2022 to the primary completion date, 31 Dec 2026
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients who did not receive immune checkpoint inhibitor therapy
Who the study is looking for
- above age 18,
- histologically and cytologically confirmed NSCLC, melanoma, head and neck squamous cell carcinoma, gastrointestinal cancers,, renal cell carcinoma, or any other solid tumors where immune checkpoint therapy has been used
- received immunotherapy as part of their treatment
- Self-identified American Indian in ethnicity
- Patients at the Stephenson Cancer Center between 2015 to 2021
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of New Mexico Comprehensive Cancer Center Coordinator of this site? Confirm its status | Albuquerque | United States | Unknown status |
| Stephenson Cancer Center Coordinator of this site? Confirm its status | Oklahoma City | United States | Unknown status |
| Monument Health Cancer Care Institute Coordinator of this site? Confirm its status | Rapid City | United States | Unknown status |
| Huntsman Cancer Institute at the University of Utah Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
| Avera Cancer Institute Coordinator of this site? Confirm its status | Sioux Falls | United States | Unknown status |
| Arizona Cancer Center at the Unvieristy of Arizona Coordinator of this site? Confirm its status | Tucson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.